Are we being able to meet current guidelines LDL-cholesterol goals in very high risk patients? How many of them could benefit of PSCK9 inhibition by the FOURIER/ODYSSEY and NICE criteria?
3 September 2019 (08:30 - 12:30)
Organised by:
Abstract
Slides
About the speaker
Dante Pazzanese Institute of Cardiology, Sao Paulo (Brazil)
13 More presentations in this session
Access the full session
The Event
ESC Congress 2019
3 September 2019
08:30 CET
